These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 15166438)

  • 1. Enhanced hepatitis C virus NS3 specific Th1 immune responses induced by co-delivery of protein antigen and CpG with cationic liposomes.
    Jiao X; Wang RY; Qiu Q; Alter HJ; Shih JW
    J Gen Virol; 2004 Jun; 85(Pt 6):1545-1553. PubMed ID: 15166438
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Priming with CpG-enriched plasmid and boosting with protein formulated with CpG oligodeoxynucleotides and Quil A induces strong cellular and humoral immune responses to hepatitis C virus NS3.
    Yu H; Babiuk LA; van Drunen Littel-van den Hurk S
    J Gen Virol; 2004 Jun; 85(Pt 6):1533-1543. PubMed ID: 15166437
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Induction of potent cellular immune response in mice by hepatitis C virus NS3 protein with double-stranded RNA.
    Jin B; Wang RY; Qiu Q; Sugauchi F; Grandinetti T; Alter HJ; Shih JW
    Immunology; 2007 Sep; 122(1):15-27. PubMed ID: 17451465
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Humoral and CD4(+) T helper (Th) cell responses to the hepatitis C virus non-structural 3 (NS3) protein: NS3 primes Th1-like responses more effectively as a DNA-based immunogen than as a recombinant protein.
    Lazdina U; Hultgren C; Frelin L; Chen M; Lodin K; Weiland O; Leroux-Roels G; Quiroga JA; Peterson DL; Milich DR; Sällberg M
    J Gen Virol; 2001 Jun; 82(Pt 6):1299-1308. PubMed ID: 11369873
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vigorous hepatitis C virus-specific CD4+ and CD8+ T cell responses induced by protein immunization in the presence of Montanide ISA720 plus synthetic oligodeoxynucleotides containing immunostimulatory cytosine-guanine dinucleotide motifs.
    Sugauchi F; Wang RY; Qiu Q; Jin B; Alter HJ; Shih JW
    J Infect Dis; 2006 Feb; 193(4):563-72. PubMed ID: 16425136
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Induction of multispecific Th-1 type immune response against HCV in mice by protein immunization using CpG and Montanide ISA 720 as adjuvants.
    Qiu Q; Wang RY; Jiao X; Jin B; Sugauchi F; Grandinetti T; Alter HJ; Shih JW
    Vaccine; 2008 Oct; 26(43):5527-5534. PubMed ID: 18675871
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of the immunogenicity of liposome encapsulated HVR1 and NS3 regions of genotype 3 HCV, either singly or in combination.
    Gupte GM; Arankalle VA
    Virol J; 2012 Mar; 9():74. PubMed ID: 22452828
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Induction of antigen-specific immune responses in vivo after vaccination with dendritic cells transduced with adenoviral vectors encoding hepatitis C virus NS3.
    Xiang M; Eisenbach C; Lupu CM; Ernst E; Stremmel W; Encke J
    Viral Immunol; 2006; 19(2):210-9. PubMed ID: 16817764
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HCV-NS3 Th1 minigene vaccine based on invariant chain CLIP genetic substitution enhances CD4(+) Th1 cell responses in vivo.
    Gao M; Wang HP; Wang YN; Zhou Y; Wang QL
    Vaccine; 2006 Jun; 24(26):5491-7. PubMed ID: 16725235
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Simultaneous use of natural adjuvants and cell penetrating peptides improves HCV NS3 antigen-specific immune responses.
    Alizadeh S; Irani S; Bolhassani A; Sadat SM
    Immunol Lett; 2019 Aug; 212():70-80. PubMed ID: 31254535
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Broadening CD4
    Filskov J; Mikkelsen M; Hansen PR; Christensen JP; Thomsen AR; Andersen P; Bukh J; Agger EM
    J Virol; 2017 Jul; 91(14):. PubMed ID: 28446674
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A novel combined vaccine candidate containing epitopes of HCV NS3, core and E1 proteins induces multi-specific immune responses in BALB/c mice.
    Zeng R; Li G; Ling S; Zhang H; Yao Z; Xiu B; He F; Huang R; Wei L
    Antiviral Res; 2009 Oct; 84(1):23-30. PubMed ID: 19646486
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dendritic cells pulsed with hepatitis C virus NS3 protein induce immune responses and protection from infection with recombinant vaccinia virus expressing NS3.
    Yu H; Huang H; Xiang J; Babiuk LA; van Drunen Littel-van den Hurk S
    J Gen Virol; 2006 Jan; 87(Pt 1):1-10. PubMed ID: 16361412
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Control of heterologous hepatitis C virus infection in chimpanzees is associated with the quality of vaccine-induced peripheral T-helper immune response.
    Rollier C; Depla E; Drexhage JA; Verschoor EJ; Verstrepen BE; Fatmi A; Brinster C; Fournillier A; Whelan JA; Whelan M; Jacobs D; Maertens G; Inchauspé G; Heeney JL
    J Virol; 2004 Jan; 78(1):187-96. PubMed ID: 14671100
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of antibody- and cell-mediated immune responses after intramuscular hepatitis C immunizations of BALB/c mice.
    Ghorbani M; Nass T; Azizi A; Soare C; Aucoin S; Giulivi A; Anderson DE; Diaz-Mitoma F
    Viral Immunol; 2005; 18(4):637-48. PubMed ID: 16359230
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunization with a Recombinant Expression Vector Encoding NS3/NS4A of Hepatitis C Virus Genotype 3a Elicits Cell-Mediated Immune Responses in C57BL/6 Mice.
    Behzadi MA; Alborzi A; Kalani M; Pouladfar G; Dianatpour M; Ziyaeyan M
    Viral Immunol; 2016 Apr; 29(3):138-47. PubMed ID: 26909520
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modulation of cellular immune response against hepatitis C virus nonstructural protein 3 by cationic liposome encapsulated DNA immunization.
    Jiao X; Wang RY; Feng Z; Alter HJ; Shih JW
    Hepatology; 2003 Feb; 37(2):452-60. PubMed ID: 12540796
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The combined application of nucleotide and amino acid sequences of NS3 hepatitis C virus protein, DNA encoding granulocyte macrophage colony-stimulating factor and inhibitor of regulatory T cells induces effective immune response against hepatitis C virus].
    Masalova OV; Lesnova EI; Shingarova LN; Tunitskaia VL; Ulanova TI; Burkov AN; Kushch AA
    Mol Biol (Mosk); 2012; 46(3):525-34. PubMed ID: 22888642
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immune responses against HCV-NS3 after accidental infection with HCV-NS3 recombinant vaccinia virus.
    Eisenbach C; Neumann-Haefelin C; Freyse A; Korsukéwitz T; Hoyler B; Stremmel W; Thimme R; Encke J
    J Viral Hepat; 2007 Nov; 14(11):817-9. PubMed ID: 17927619
    [No Abstract]   [Full Text] [Related]  

  • 20. Vaccination with an adenoviral vector encoding hepatitis C virus (HCV) NS3 protein protects against infection with HCV-recombinant vaccinia virus.
    Arribillaga L; de Cerio AL; Sarobe P; Casares N; Gorraiz M; Vales A; Bruna-Romero O; Borrás-Cuesta F; Paranhos-Baccala G; Prieto J; Ruiz J; Lasarte JJ
    Vaccine; 2002 Dec; 21(3-4):202-10. PubMed ID: 12450695
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.